phenylacetic acid has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, R; Lieberman, FS; Manley, GT; Rosenblum, MK; Samid, D; Stockhammer, G | 1 |
| Myers, CE; Samid, D; Shack, S | 1 |
2 other study(ies) available for phenylacetic acid and transforming growth factor beta
| Article | Year |
|---|---|
Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate.
Topics: Animals; Astrocytoma; Cell Differentiation; Cell Division; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; ELAV Proteins; G1 Phase; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Humans; Medulloblastoma; Mice; Nerve Tissue Proteins; Neuroblastoma; Neurofilament Proteins; Neuroglia; Neurons; Phenotype; Phenylacetates; Rats; Resting Phase, Cell Cycle; RNA-Binding Proteins; Schwann Cells; Transforming Growth Factor beta | 1995 |
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
Topics: Animals; Cell Division; Cell Survival; DNA Replication; Female; Glutamine; HLA-A3 Antigen; Humans; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Phenotype; Phenylacetates; Prostatic Neoplasms; RNA, Neoplasm; Suramin; Transforming Growth Factor beta; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |